Appointments

Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

Videos

  •   Email
  •   Print
  •   Share
  • Report from the 2011 San Antonio Breast Cancer Symposium
  • 4:53
  • Harold Burstein, MD, PhD, provides an overview of the latest in breast cancer research presented at the 2011 San Antonio Breast Cancer Symposium, including findings of the CLEOPATRA trial, which looked at combining pertuzumab with trastuzumab and docetaxel in women with metastatic HER2-positive disease; the BOLERO-2 trial, which focused on combining everolimus and exemestane in women with metastatic breast cancer; and the controversy surrounding the effectiveness of osteoporosis drugs in preventing breast cancer.

Tags: BreastCancer